China Journal of Leprosy and Skin Diseases ›› 2020, Vol. 36 ›› Issue (11): 697-700.doi: 10.12144/zgmfskin202011697

• Reviews • Previous Articles     Next Articles

Update of epidermal growth factor receptor signaling pathway in the pathogenesis of related skin diseases

WANG Wenzhu1, HE Yanyan1,2, XU Haoxiang1   

  1. 1 Institute of Dermatology, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing 210042, China; 2 Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing 210042, China
  • Online:2020-11-15 Published:2020-11-02
  • Contact: HE Yanyan, E-mail: heyanyan.jsnj@163.com; XU Haoxiang, E-mail: xbpipi@163.com

Abstract: Epidermal growth factor receptor (EGFR) is one kind of receptor tyrosine kinase, which exists in the membrane of almost all epithelial cells and many mesenchymal cells. The imbalance of EGFR pathway may lead to cell proliferation, angiogenesis, apoptosis damage, cell invasion enhancement, and participate in the pathogenesis of skin inflammation and skin tumor. The update of EGFR pathway in the pathogenesis of related skin diseases is reviewed in this paper.

Key words: epidermal growth factor receptor, mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)